[Double depression].
Kaji
Kyoko
K
Department of Psychiatry, University of Occupational and Environmental Health.
Yoshimura
Reiji
R
Nakamura
Jun
J
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology / Q000628:therapy; D003865:Major Depressive Disorder / Q000209:etiology; D039721:Diagnostic and Statistical Manual of Mental Disorders; D018450:Disease Progression; D004359:Drug Therapy, Combination; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011613:Psychotherapy; D012015:Reference Standards; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D016666:Fluvoxamine; D008094:Lithium; D017367:Selective Serotonin Reuptake Inhibitors